Literature DB >> 11911846

Pharmacological characterization of the ATP-dependent low K(m) guanosine 3',5'-cyclic monophosphate (cGMP) transporter in human erythrocytes.

Elisabeth Sundkvist1, Ragnhild Jaeger, Georg Sager.   

Abstract

The efflux pump for cGMP has been shown to be an ATP-energized multiorganic anion transporter. The present study was performed to extend the knowledge of the pharmacological characteristics of this efflux pump. Inside-out vesicles prepared from fresh blood were incubated with [3H]-cGMP (1 microM) with or without various concentrations of competitors for 120min at 37 degrees. The tested compounds could be divided in four groups: one with high affinity (K(i) < 5 microM), a second with moderate affinity (K(i): 5-50 microM), a third with low affinity (K(i): 0.1-5mM) and the fourth with extremely low or no affinity at all. With the mean K(i)-values given in parenthesis, the high affinity group consisted of mifepristone (0.2 microM), zaprinast (0.35 microM), dipyridamole (0.35 microM), estradiol 3-beta-glucuronide (0.42 microM), genistein (0.43 microM), estradiol 17-beta-glucuronide (0.47 microM), onapristone (1.3 microM), progesterone (1.7 microM) and sildenafil (3.6 microM). The inhibitors with medium affinity were estradiol (8 microM), sulfinpyrazone (13 microM), daunorubicin (23 microM), megestrol acetate (26 microM), doxorubicin (28 microM), 6-thioguanine (28 microM) and 6-thioguanosine-5'-monophosphate (32 microM). The low affinity group comprised 6-TIMP (220 microM), 6-methylmercaptopurine (MMP) (220 microM), vincristine (270 microM), medroxyprogesterone (680 microM), para-aminohippurate (PAH) (1.9mM) and taurocholate (2.2mM). No or minimal effect was seen in the presence of 6-mercaptopurine (6-MP), methotrexate, 9-(2-phosphonylmethoxyethyl)adenine and mitoxantrone. The cGMP transporter had a unique pharmacological profile, different from that of MRP1, but with some characteristics in common with MRP4 and MRP5.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11911846     DOI: 10.1016/s0006-2952(01)00940-6

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  8 in total

1.  Novel cGMP efflux inhibitors identified by virtual ligand screening (VLS) and confirmed by experimental studies.

Authors:  Georg Sager; Elin Ø Ørvoll; Roy A Lysaa; Irina Kufareva; Ruben Abagyan; Aina W Ravna
Journal:  J Med Chem       Date:  2012-03-20       Impact factor: 7.446

Review 2.  Multidrug resistance-associated proteins 3, 4, and 5.

Authors:  Piet Borst; Cornelia de Wolf; Koen van de Wetering
Journal:  Pflugers Arch       Date:  2006-04-04       Impact factor: 3.657

3.  A role for multidrug resistance protein 4 (MRP4; ABCC4) in human dendritic cell migration.

Authors:  Rieneke van de Ven; George L Scheffer; Anneke W Reurs; Jelle J Lindenberg; Ruud Oerlemans; Gerrit Jansen; Jean-Pierre Gillet; Joel N Glasgow; Alexander Pereboev; David T Curiel; Rik J Scheper; Tanja D de Gruijl
Journal:  Blood       Date:  2008-07-14       Impact factor: 22.113

4.  The role of multidrug resistance protein 1 (MRP1) in transport of fluorescent anions across the human erythrocyte membrane.

Authors:  B Rychlik; A Balcerczyk; A Klimczak; G Bartosz
Journal:  J Membr Biol       Date:  2003-05-15       Impact factor: 1.843

5.  Differential expression of multidrug resistance protein 5 and phosphodiesterase 5 and regulation of cGMP levels in phasic and tonic smooth muscle.

Authors:  Othman Al-Shboul; Sunila Mahavadi; Wimolpak Sriwai; John R Grider; Karnam S Murthy
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-06-13       Impact factor: 4.052

Review 6.  Multidrug resistance associated proteins in multidrug resistance.

Authors:  Kamlesh Sodani; Atish Patel; Rishil J Kathawala; Zhe-Sheng Chen
Journal:  Chin J Cancer       Date:  2011-11-18

7.  Inhibition of PDE5A1 guanosine cyclic monophosphate (cGMP) hydrolysing activity by sildenafil analogues that inhibit cellular cGMP efflux.

Authors:  Anna Subbotina; Aina W Ravna; Roy A Lysaa; Ruben Abagyan; Ryszard Bugno; Georg Sager
Journal:  J Pharm Pharmacol       Date:  2017-02-17       Impact factor: 3.765

8.  Inhibition of hyaluronan export reduces collagen degradation in interleukin-1 treated cartilage.

Authors:  Barthold Deiters; Peter Prehm
Journal:  Arthritis Res Ther       Date:  2008-01-18       Impact factor: 5.156

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.